Celcuity

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Celcuity and other ETFs, options, and stocks.

About CELC

Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. 

CEO
Brian F. Sullivan
CEOBrian F. Sullivan
Employees
87
Employees87
Headquarters
Minneapolis, Minnesota
HeadquartersMinneapolis, Minnesota
Founded
2012
Founded2012
Employees
87
Employees87

CELC Key Statistics

Market cap
2.29B
Market cap2.29B
Price-Earnings ratio
-15.23
Price-Earnings ratio-15.23
Dividend yield
Dividend yield
Average volume
927.02K
Average volume927.02K
High today
$54.76
High today$54.76
Low today
$51.72
Low today$51.72
Open price
$52.44
Open price$52.44
Volume
635.65K
Volume635.65K
52 Week high
$63.06
52 Week high$63.06
52 Week low
$7.58
52 Week low$7.58

CELC News

Simply Wall St 1d
The Bull Case For Celcuity Could Change Following Expanded Credit Facility and Rising Commercial Ambitions

Celcuity Inc. was recently added to the S&P Biotechnology Select Industry Index and announced an amended senior secured credit facility that expands its total t...

The Bull Case For Celcuity Could Change Following Expanded Credit Facility and Rising Commercial Ambitions
TipRanks 3d
Celcuity initiated with a Buy at Guggenheim

Guggenheim initiated coverage of Celcuity (CELC) with a Buy rating and $110 price target Published first on TheFly – the ultimate source for real-time, market-...

Simply Wall St 3d
Celcuity: Evaluating Valuation After FDA Nod for Gedatolisib and Financial Facility Expansion

Celcuity (CELC) just made headlines with a flurry of news that is hard to ignore if you're weighing your next move. The company not only received FDA acceptance...

Celcuity: Evaluating Valuation After FDA Nod for Gedatolisib and Financial Facility Expansion

Analyst ratings

100%

of 9 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own CELC. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.